The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
Strategic Alliance for The Development of Diagnostic Biomarker Panels for Hepatitis and Liver Cancer
1 other identifier
observational
1,600
1 country
8
Brief Summary
More recent studies have shown that the HBV-infected population has a greater risk of development of hepatocellular carcinoma. Nevertheless, there are still a significant number of people chronically infected by HBV who do not develop the complication. Hence, there exist biological markers that could be indicator for the disease-inducing and carcinogenic potential of the virus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2010
8 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2010
CompletedFirst Submitted
Initial submission to the registry
March 4, 2011
CompletedFirst Posted
Study publicly available on registry
March 7, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2012
CompletedMarch 7, 2011
March 1, 2011
March 4, 2011
March 4, 2011
Conditions
Keywords
Eligibility Criteria
Selected hospitals for study
You may qualify if:
- Patients of at least 21 years old on day of giving consent for study
- Patients must be able and wiling to give an informed consent
- Patient with chronic HBV infection
- Patient with active hepatocellular carcinoma and chronic hepatitis B
- Healthy subjects
You may not qualify if:
- Patients who have co-infection with HIV or chronic hepatitis C
- Subjects with other types of cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ministry of Health, Malaysialead
- GeneNews Sdn Bhdcollaborator
Study Sites (8)
Sultanah Bahiyah Hospital
Alor Star, Kedah, Malaysia
Kuala Lumpur Hospital
Kuala Lumpur, Kuala Lumpur, Malaysia
Island Hospital
Pulau Pinang, Pulau Pinang, Malaysia
Lam Wah Ee Hospital
Pulau Pinang, Pulau Pinang, Malaysia
Penang Hospital
Pulau Pinang, Pulau Pinang, Malaysia
Queen Elizabeth Hospital
Kota Kinabalu, Sabah, Malaysia
Hospital Umum Kuching Sarawak
Kuching, Sarawak, Malaysia
Selayang Hospital
Selayang Baru Utara, Selangor, Malaysia
Biospecimen
Red blood cell and white blood cell
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
March 4, 2011
First Posted
March 7, 2011
Study Start
August 1, 2010
Study Completion
August 1, 2012
Last Updated
March 7, 2011
Record last verified: 2011-03